Skip to content
★ Sign in to follow
SG

SSY Group Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$7.6BHealth Care

1 insider bought €7.2M of shares over the last 90 days, the latest by Qu Jiguang, filed 06 Nov 2026.

SSY Group Ltd.: what insiders have been doing

This page follows insider dealings at SSY Group Ltd. as filed with HKEX, a company from the Health Care sector. In the past year (6 November 2025 to 6 November 2026), 45 filings came from 4 insiders.

Every open-market trade in the period is a purchase: 42 purchases worth €155.3M, from 1 insider, and not a single sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 1 senior executive. The largest single trade was a purchase of €53.2M by Qu Jiguang, published on 18 May 2026, equal to 7.0% of the market capitalisation.

With 45 filings in twelve months, the company is more active than the median of 4 filings across the 1,323 companies we follow on the same exchange. Over the whole record (from 2018), the tally stands at 212 purchases and no sales.

The most recent open-market purchase was published on 6 November 2026, 2 days ago. Publication is fast: at least half of the trades appear on HKEX on the same day. The shorter that gap, the sooner other investors can see what insiders have done.

In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. This summary is built from HKEX disclosures alone and does not predict where the share price will go.

Insider Decl.
228
Thresholds
n/a
Buy Volume
€244M
212 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Qu Jiguang75 buys

Since the insiders bought

  • Filed 29 Oct 2026 · 10 days ago · €447k
    +0.8%
    Entry HK$2.60 · Close 04 Nov 2026 HK$2.62

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 10,159 of 26,897 companies
57.6
score / 100
Value
61
Quality
54
FCF yld4.0%
Earn yld6.2%
EV/EBITDA10.3x
ROE6.6%
Gross mgn42%
Net mgn11%
Debt/EBITDA3.6x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$2.64
Analyst consensus
2 analysts
1.00/5
HK$3.44Target HK$3.93(+49%)HK$4.41
Income statement
RevenueHK$4.2B
Gross profitHK$1.7B42% margin
EBITDAHK$1.1B27% margin
Net incomeHK$470.6M11.6% margin
Valuation
PER (trailing)14.6x
PER (forward)10.5x
P/Book1.0x
Beta0.54
Balance sheet & cash
Market capHK$7.6B
Total debtHK$4B
Free Cash FlowHK$299.8M
Debt / Equity50%
Profitability & ownership
ROE6.6%
ROA3.2%
% insiders66.7%
% institutions10.3%
Last declaration on 6 November 2026
Declarations228 total
  • ▲
    DirectorExecutives
    3M HKD0HKEX
    1,000,000 shares@ HK$2.649ShareXHKGHKEX:DA20261106E00361
    Canonical exit: 4 Feb 2027 (T+90)
  • ▲
    DirectorExecutives
    4M HKD19HKEX
    1,500,000 shares@ HK$2.6070.053% mcap0.3% of flowShareXHKGHKEX:DA20261029E00334
    Canonical exit: 27 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    3M HKD18HKEX
    1,200,000 shares@ HK$2.61040.042% mcap0.3% of flowShareXHKGHKEX:DA20261027E00401
    Canonical exit: 25 Jan 2027 (T+90)
  • ▲
    DirectorExecutives
    1M HKD16HKEX
    500,000 shares@ HK$2.76960.017% mcap1.3% of flowShareXHKGHKEX:DA20261002E00517
    Canonical exit: 31 Dec 2026 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    24,416,000 sharesShareXHKGHKEX:DA20260929E00274
  • ▲
    DirectorExecutives
    4M HKD19HKEX
    1,500,000 shares@ HK$2.78120.053% mcap0.3% of flowShareXHKGHKEX:DA20260929E00261
    Canonical exit: 28 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    1M HKD16HKEX
    500,000 shares@ HK$2.76950.017% mcap1.3% of flowShareXHKGHKEX:DA20260925E00341
    Canonical exit: 24 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    2M HKD17HKEX
    700,000 shares@ HK$2.79280.025% mcap1.8% of flowShareXHKGHKEX:DA20260924E00367
    Canonical exit: 23 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    3M HKD19HKEX
    1,250,000 shares@ HK$2.7970.044% mcap3.2% of flowShareXHKGHKEX:DA20260923E00412
    Canonical exit: 22 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    3M HKD18HKEX
    1,000,000 shares@ HK$2.76240.034% mcap0.2% of flowShareXHKGHKEX:DA20260922E00331
    Canonical exit: 21 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    2M HKD17HKEX
    800,000 shares@ HK$2.74950.027% mcap0.2% of flowShareXHKGHKEX:DA20260921E00222
    Canonical exit: 20 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    3M HKD18HKEX
    1,150,000 shares@ HK$2.73360.039% mcap0.3% of flowShareXHKGHKEX:DA20260918E00446
    Canonical exit: 17 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    4M HKD19HKEX
    1,400,000 shares@ HK$2.76750.048% mcap0.3% of flowShareXHKGHKEX:DA20260917E00369
    Canonical exit: 16 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    2M HKD18HKEX
    850,000 shares@ HK$2.71060.028% mcap0.2% of flowShareXHKGHKEX:DA20260916E00445
    Canonical exit: 15 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    4M HKD19HKEX
    1,400,000 shares@ HK$2.69440.046% mcap0.3% of flowShareXHKGHKEX:DA20260915E00399
    Canonical exit: 14 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    8M HKD21HKEX
    3,200,000 shares@ HK$2.61580.10% mcap0.7% of flowShareXHKGHKEX:DA20260914E00340
    Canonical exit: 13 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    3M HKD18HKEX
    1,000,000 shares@ HK$2.6210.032% mcap0.2% of flowShareXHKGHKEX:DA20260911E00425
    Canonical exit: 10 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    2M HKD18HKEX
    870,000 shares@ HK$2.6230.029% mcap0.2% of flowShareXHKGHKEX:DA20260910E00289
    Canonical exit: 9 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    2M HKD18HKEX
    880,000 shares@ HK$2.73110.030% mcap0.2% of flowShareXHKGHKEX:DA20260909E00342
    Canonical exit: 8 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    4M HKD19HKEX
    1,300,000 shares@ HK$2.70840.045% mcap0.3% of flowShareXHKGHKEX:DA20260908E00296
    Canonical exit: 7 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    3M HKD18HKEX
    1,000,000 shares@ HK$2.74380.035% mcap0.2% of flowShareXHKGHKEX:DA20260907E00251
    Canonical exit: 6 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    2M HKD18HKEX
    850,000 shares@ HK$2.75060.030% mcap0.2% of flowShareXHKGHKEX:DA20260904E00280
    Canonical exit: 3 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    3M HKD11HKEX
    1,300,000 shares@ HK$2.37280.045% mcap0.2% of flowShareXHKGHKEX:DA20260521E00315
    Canonical exit: 19 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    5M HKD14HKEX
    2,000,000 shares@ HK$2.31335.54% mcap28.1% of flowShareXHKGHKEX:DA20260520E00215
    Canonical exit: 18 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    5M HKD14HKEX
    2,000,000 shares@ HK$2.35325.63% mcap28.6% of flowShareXHKGHKEX:DA20260519E00328
    Canonical exit: 17 Aug 2026 (T+90)

25 of 228 declarations

About SSY Group Ltd.

SSY Group Ltd. is a company focused on the healthcare and pharmaceutical sector, providing health-related products and services. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations